Background and objectives: Pterygium is a non-cancerous growth of conjunctival tissue that can extend onto the corneal surface. The presence of some oncogenic viruses in pterygium and the neoplastic nature of these lesions led us to the postulated involvement of the viruses in the etiology of pterygium. Given the association of human herpesvirus 6 (HHV-6) with ocular diseases, we aimed to investigate presence of this virus in pterygium.
INTRODUCTION
Pterygium is a common ocular lesion that appears as wing-shaped, vascular and fleshy growth that can extend onto the corneal surface. The disease is relatively common in the general population and thought to be caused by ultraviolet-light exposure, low humidity and dust (1) . Much attention has recently been paid to the possibility of viral oncogenes involvement in the multistage process of pterygium formation. Until now, a few viruses such as human papillomaviruses (HPV) and Epstein-Barr virus (EBV) have been investigated as possible causative agents of pterygium (2, 3) . Human herpesvirus 6 (HHV-6) belongs to the Roseolovirus genus of the Betaherpesvirinae subfamily and has a linear, double-stranded genome. The virus was first isolated in 1986 from AIDS patients with lymphoproliferative disorders (4). HHV-6 is an opportunistic pathogen with up to 90% seroprevalence in the human population and is commonly acquired during early childhood. The virus is separated into two major subgroups, HHV-6A and -6B, on the basis of genetic, immunological, epidemiological and functional features (4, 5) . Primary infection with HHV-6B can cause roseola (also known as sixth disease or exanthem subitum), a common childhood disease that resolves spontaneously. Although, HHV-6 infections are usually benign, the virus has been associated with several neurologic syndromes, such as febrile convulsions, encephalitis and multiple sclerosis. Besides roseola infantum, research on causative role of HHV-6 in other illnesses has been inconclusive (1, (6) (7) (8) .
Overall, HHV-6 variant B is found more frequently than variant A in both peripheral blood mononuclear cells and solid tissues (5, 9) . Variant A is predominantly present in the skin and active in nearly all Lyme disease patients. In some cases, both variants can coexist in the brain despite being localized in different brain areas (5, 9, 10) . In addition, HHV-6 is reported to be associated with different cancers including Hodgkin's lymphoma (HL), T-cell leukemia, EBVnegative B-cell lymphoma, African Burkitt's lymphoma and adenomatous gastrointestinal polyps (6, (11) (12) (13) . Given the association of HHV-6 with ocular diseases, we aimed to investigate presence of this virus in pterygium.
were postoperative recurrence. In the clinical examination for grading pterygia, 14 (28%) were atrophic/grade 1, 17 (34%) were intermediate/grade 2 and 19 (38%) were fleshy/grade 3. A positive family history of pterygium was noted in two cases (4%). Five positive cases (10%) had a history of outdoor activities. Seven patients (14%) had a positive smoking history. Six (12 %) patients with pterygium were positive for HHV-6 DNA ( Table 1) . PCR of the β-globin gene was used as an internal control for DNA extraction, which showed that all samples were β-globin positive. There was no statistically significant correlation between pterygium and the presence of HHV-6.
Prevalence of positive samples was calculated at 95% confidence interval (CI). Chi-square test and Fisher's exact test were used to evaluate distribution of characteristics associated with HHV-6 infection. Statistical significance was set at 0.05 for statistical analyses. Demographic and clinical data were entered and analyzed with SPSS software (version 18).
RESULTS
Of 50 specimens examined in this study, 20 (40%) were collected from males and 30 (60%) were from females. Utilization of virus-specific laboratory assays including fluorescence in situ hybridization, loop-mediated isothermal amplification and immunohistochemistry could also be effective for clarifying virus replication in the lesion (6, 23, 24, 29) . Recently, studies introduced a highly precise diagnostic tool named droplet digital-PCR, which has lower variability and outstanding quantification accuracy (26) . Our results suggest that HHV-6 infection may be just a bystander that creates an immunosuppressive milieu, which could contribute to disease severity. Elucidating whether the virus plays an oncogenic role in pterygium requires a more in-depth investigation.
CONCLUSION
Based on the results, a direct association between HHV-6 and development of pterygium seems less probable, which suggests that other etiologic agents must be involved in the multistep process of the disease.
DISCUSSION
Many different genetic and environmental factors have been proposed to be involved in development of pterygium, but none has been found to be directly linked to the lesion formation. The potential role of viral infections with HPV, EBV and herpes simplex virus as well as exogenous agents including ultraviolet irradiation in the development of pterygium remains controversial. However, since the disease creates a unique and favorable environment for viral oncogenes, viruses might have a role in progression of the lesions (2). Cell proliferation, interference with signaling pathways, resistance to apoptosis and inducing angiogenesis are the hallmarks of pterygium, all of which support the neoplastic nature of the lesion (16) . However, pterygia are benign growths and typically do not require surgical excision until manifestation of acute symptoms, but recurrence is frequent after tissue excision (as high as 46%) (17) . Some studies have suggested an association between HHV-6 and ocular disease, corneal inflammation, optic neuropathy, tonic pupil, bilateral uveitis and Bell's palsy. These results suggest that HHV-6 may be capable of invading the corneal tissue (6, (18) (19) (20) (21) (22) (23) (24) . Although HHV-6 is identified as an opportunistic virus, it has also shown transforming and trans-activating properties, thus playing a definitive role in human neoplasia (6, 9) . The detection of HHV-6 viral DNA sequences in some Hodgkin's and non-Hodgkin's lymphomas indicates the possible role of HHV-6 in human neoplasia (25, 26) . The vast majority of studies utilized nested-PCR for diagnosing infection with HHV-6. Since pterygium usually grows slowly through life, even with this sensitive and specific technique, 30-60% of patients remain undiagnosed, because the HHV-6 may be chronically active in the tissue and only limited number of viruses circulate outside the tissue. Hence, real-time PCR must be sensitive-enough to detect HHV-6 infections in the tissues (24, 25, 27) . In our study, the HHV-6 DNA was found in 6 (12%) patients using real-time PCR. The limitation of this study were the small
